HIV PREVENTION

This study tests whether a smartphone app (DynamiCare) plus a patient navigator can help people recently released from jail or prison reduce their use of stimulants like methamphetamine or cocaine and start HIV prevention (PrEP) or treatment (ART). The pilot phase will enroll 40 …

This study tests a mobile health program called PrEP Choice to help young people (ages 13-24) start and stick with HIV prevention medication (PrEP). It also looks at whether taking a pill called DoxyPEP after sex can prevent other STIs. About 200 participants at higher risk for H…

This study looks at how to keep HIV self-test kits freely available to adolescent girls and young women in sub-Saharan Africa through local drug shops and pharmacies. Researchers will test different ways to support shop owners, like small payments and encouragement, to keep givin…

This study tests a quick digital toolkit that helps cisgender women learn about PrEP, a daily pill that prevents HIV. About 125 women in Alabama and Mississippi will use the toolkit on a tablet at their clinic and then talk with a healthcare provider about starting PrEP. Research…

This study tests a program called LINKED that uses social networks to encourage people who inject drugs to start HIV prevention medication (PrEP) and medication for opioid use disorder (MOUD). About 400 participants in Los Angeles will be randomly assigned to the LINKED program o…

This study tests two programs to help Black men who have sex with men take their daily HIV prevention pills (PrEP) more regularly. About 500 participants will receive either a care coordination program or that program plus extra behavioral support sessions. Researchers will track…

This pilot study tests whether trained young mentor mothers (YMMs) can help pregnant and breastfeeding girls and young women (ages 15-24) in Zimbabwe use HIV prevention tools like PrEP and contraception. About 600 participants will be assigned to receive support from YMMs or stan…

This study trains 75 community pharmacists in Louisiana to prescribe PrEP, a daily pill that prevents HIV. The goal is to make PrEP more available, especially in underserved areas. Researchers will measure how many prescriptions are written and test pharmacists' knowledge and con…

This study will test a chatbot designed to help Black men who have sex with men in the Southern United States learn about and use PrEP, a daily pill that prevents HIV. About 145 participants will use the chatbot and report their PrEP awareness and use over 90 days. The goal is to…

This study aims to see if video logs and personalized messages can encourage Black women in Texas to start taking PrEP, a daily pill that prevents HIV, and encourage their doctors to prescribe it. About 78 Black women and their healthcare providers will participate. The goal is t…

This study tests a program called PrEP & Soccer, run through CVS pharmacies, to help men learn about and get PrEP (a daily pill that prevents HIV). The program uses soccer-themed materials to reach men, especially Latino men who have sex with men. Researchers will see if this app…

This study looks at how moving to the U.S. and forming relationships affects HIV prevention decisions, like testing and PrEP use, among African immigrants aged 18 to 50 in New York and Massachusetts. Researchers will interview participants and hold group discussions to co-create …